Workflow
Figma Q3 Earnings: Shareholders Diluted By Massive 13x
Seeking Alpha· 2025-11-07 21:06
Uttam is a growth-oriented investment analyst whose equity research primarily focuses on the technology sector. Semiconductors, Artificial Intelligence and Cloud software are some of the key sectors that are regularly researched and published by him. His research also focuses on other areas such as MedTech, Defense Tech, and Renewable Energy. In addition, Uttam also authors The Pragmatic Optimist Newsletter along with his wife, Amrita Roy, who is also an author on the newsletter as well as on this platform. ...
Jim Cramer: Own This Consumer Cyclical Stock And Don't Sell It
Benzinga· 2025-11-07 21:05
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended owning TJX (NYSE:TJX) and not selling it. “TJX is really, really strong. It's what works in a bad market,” he added.Supporting his view, BTIG analyst Robert Drbul initiated coverage of TJX on Oct. 15 with a Buy rating and a $165 price target.Dave & Buster's (NASDAQ:PLAY) is “so, so low,” Cramer said. “I got to do homework, it's too difficult a situation for me to say ‘yeah, I bless it.'"Freedom Capital Markets analyst Lynne Collier, on Nov. 6, in ...
Tredegar Reports Third Quarter 2025 Results
Businesswire· 2025-11-07 21:05
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR REPORTS THIRD QUARTER 2025 RESULTS. ...
Treace Announces Participation in Two Upcoming Investor Conferences
Globenewswire· 2025-11-07 21:05
PONTE VEDRA, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will participate in the following upcoming investor conferences. The UBS Global Healthcare Conference on Monday, November 10, 2025, with a fireside chat at 11:45 am ET; andThe Stifel 2025 Healthcare Conference on Tuesday, November 11, 20 ...
International Tower Hill Mines Files 2025 Third Quarter Financial Results
Prnewswire· 2025-11-07 21:05
Accessibility StatementSkip Navigation more press release views with Request a Demo VANCOUVER, BC, Nov. 7, 2025 /PRNewswire/ - International Tower Hill Mines Ltd. (the "Company") - (TSX: ITH) (NYSE American: THM) today announced that it has filed its unaudited third quarter Financial Statements and associated Management Discussion and Analysis and Quarterly Report on Form 10-Q for the three- and nine-month period ended September 30, 2025. Shareholders can obtain copies of the Company's unaudited third quar ...
IMUNON R&D Day: Opportunity to Hear Clinical Trial Investigators Discuss Significant Potential of IMNN-001 to Redefine Ovarian Cancer Treatment
Globenewswire· 2025-11-07 21:05
Investors and stakeholders invited to attend in person in New York City or via live webcast on Monday, November 10th at 8:00 a.m. ET LAWRENCEVILLE, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, will host an R&D Day on Monday, November 10, 2025 at 8:00 a.m. ET in New York City featuring in-depth discussions with experts including principal investigators leading the Phase 3 OVATION 3 clinical trial and ...
Altimmune Presents AI-Based Analysis of Liver Fibrosis Reduction from IMPACT Phase 2b Trial of Pemvidutide in MASH in Late-breaking Poster at AASLD The Liver Meeting® 2025
Globenewswire· 2025-11-07 21:05
AI-based digital pathology analysis provides high-resolution quantification of hepatic fibrosis and objective measurement of fibrosis improvement Pemvidutide demonstrated significant reductions in liver fibrosis and improvements in non-invasive tests vs. placebo at 24 weeks GAITHERSBURG, Md., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced resu ...
Nasdaq tipped to lead the decline when trading starts
Proactiveinvestors NA· 2025-11-07 21:04
About this content About Stephen Gunnion Stephen Gunnion is a senior financial journalist and broadcaster at Proactive Investors. He has more than 25 years of experience in television, radio and print media, anchoring on a number of television channels including South Africa's Business Day TV, CNBC Africa and the South African Broadcasting Corporation, where he was the economics editor. He has also worked for Daily Maverick, Bloomberg, the Business Day newspaper and Investors' Chronicle. Read more About ...
Arkema S.A. 2025 Q3 - Results - Earnings Call Presentation (OTCMKTS:ARKAY) 2025-11-07
Seeking Alpha· 2025-11-07 21:03
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
PTX Metals Inc. Reports Compilation of Geophysical Data and Ongoing Activities at Its W2 Cu-Ni-PGEs Project
Newsfile· 2025-11-07 21:03
PTX Metals Inc. Reports Compilation of Geophysical Data and Ongoing Activities at Its W2 Cu-Ni-PGEs ProjectNovember 07, 2025 8:03 AM EST | Source: PTX Metals Inc.Toronto, Ontario--(Newsfile Corp. - November 7, 2025) - PTX Metals Inc. (TSXV: PTX) (OTCQB: PANXF) (FSE: 9PX) ("PTX" or the "Company") is pleased to report positive results of the 3D inversion processed from the 2025 magnetic survey ("Mag Survey") at its W2 Copper-Nickel and Platinum-Palladium-Gold (PGEs) Project in Ontario, Canada. T ...